The ag-bio giant and the CRISPR research tools company will cross-license patents and collaborate to further develop the genome editing toolkit.
The organization's bioethics committee called for a moratorium on germline editing and regulations on personal genomic testing.
Post-transcription editing of RNAs could help scientists investigate cancer progression, discover new biomarkers, and suggest treatment targets.
Jennifer Doudna sat down with GenomeWeb to talk about being tipped for the Nobel Prize, teaching CRISPR to undergrads, and the public perception of the technology.
The findings reveal a new layer of complexity around the role of microRNAs and highlight how race can influence their role in cancer and potentially other diseases.
In Genome Research this week: vervet genome, tandem repeats affect gene expression in great apes, and more.
Wired's Sarah Zhang writes that the fight over who developed the CRISPR/Cas9 genome editing tool first underscores the history of parallel discoveries in science.
Recent research indicates that the benefit of having a number of scientists all living and working in a certain area is eroding.
Tomas Lindahl, Paul Modrich, and Aziz Sancar share this year's Nobel Prize in Chemistry for their studies of DNA repair mechanisms.